Eraxis® (anidulafungin) – Expanded indication
September 22, 2020 - The FDA approved Pfizer’s Eraxis (anidulafungin), for the treatment of candidemia and the following Candida infections: intra-abdominal abscess and peritonitis in adults and pediatric patients 1 month of age and older.
Download PDF
